Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Recidief arterieel herseninfarct bij kinderen
jan 2017
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen